{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T18:12:52Z","timestamp":1775067172561,"version":"3.50.1"},"reference-count":122,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","internationaljournalofcardiology.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["International Journal of Cardiology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/j.ijcard.2016.07.115","type":"journal-article","created":{"date-parts":[[2016,7,17]],"date-time":"2016-07-17T11:02:03Z","timestamp":1468753323000},"page":"509-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"special_numbering":"C","title":["A joint allergist\/cardiologist classification for thienopyridines hypersensitivity reactions based on their symptomatic patterns and its impact on the management strategies"],"prefix":"10.1016","volume":"222","author":[{"given":"G.F.","family":"Calogiuri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Al-Sowaidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"E.","family":"Nettis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G.","family":"Cortellini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L.","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A.","family":"Vacca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"N.G.","family":"Kounis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ijcard.2016.07.115_bb0005","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1161\/01.CIR.100.15.1667","article-title":"Ticlopidine and clopidogrel","volume":"100","author":"Quinn","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0010","first-page":"2239i","article-title":"Guidelines for percutaneous coronary intervention","volume":"37","author":"ACC\/AHA","year":"2001","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0015","first-page":"8","article-title":"Thienopyridines: platelets ADP receptor antagonist","volume":"1","author":"Girja","year":"2011","journal-title":"J. Drug Deliv. Ther."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0020","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1016\/j.jacc.2006.11.044","article-title":"Variability in individual responsiveness to clopidogrel: clinical implications, management, and future perspectives","volume":"49","author":"Angiolillo","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0025","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1093\/eurheartj\/ehp296","article-title":"P2Y12 inhibitors: differences in properties and mechanisms of action and potential consequences for clinical use","volume":"30","author":"Wallentin","year":"2009","journal-title":"Eur. Heart J."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0030","doi-asserted-by":"crossref","first-page":"1538","DOI":"10.1345\/aph.1E119","article-title":"Neutropenia due to clopidogrel in a patient with end-stage renal disease","volume":"38","author":"Akcay","year":"2004","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0035","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1177\/106002800303700211","article-title":"Clopidogrel-associated leucopenia","volume":"37","author":"McCarthy","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0040","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/01.mjt.0000212708.81034.22","article-title":"Hematologic adverse effects of clopidogrel","volume":"14","author":"Balamuthusamy","year":"2007","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0045","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/S0140-6736(00)04599-2","article-title":"Clopidogrel and aplastic anaemia","volume":"357","author":"Meyer","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0050","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S0140-6736(00)04015-0","article-title":"Fatal aplastic anemia associated with clopidogrel","volume":"357","author":"Trivier","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0055","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1046\/j.0902-4441.2003.00165.x","article-title":"Fatal toxic bone marrow failure associated with clopidogrel","volume":"71","author":"Chemnitz","year":"2003","journal-title":"Eur. J. Haematol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0060","first-page":"52","article-title":"Acute severe pancytopenia associated with clopidogrel","volume":"70","author":"Matthews","year":"2009","journal-title":"Br. J. Hosp. Med."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0065","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.1111\/j.1538-7836.2005.01436.x","article-title":"The incidence of thrombotic thrombocytopenic purpura-hemolytic uremic syndrome: all patients, idiopathic patients, and patients with severe ADAMTS-13 deficiency","volume":"3","author":"Terrell","year":"2005","journal-title":"J. Thromb. Haemost."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0070","first-page":"S20","volume":"112","year":"2009","journal-title":"Kidney Int. Suppl."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0075","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.jacc.2007.04.093","article-title":"Two mechanistic pathways for thienopyridine-associated thrombotic thrombocytopenic purpura. A report from the SERF-TTP Research Group and the RADAR Project","volume":"50","author":"Bennett","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0080","doi-asserted-by":"crossref","DOI":"10.1056\/NEJM199811263392202","article-title":"Von Willebrand factor-cleaving protease in thrombotic thrombocytoppenia purpura and the hemolytic-uremic syndrome","volume":"339","author":"Furlan","year":"1998","journal-title":"NEJM"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0085","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.thromres.2011.03.010","article-title":"Epitope analysis of autoantibodies to ADAMTS13 in patients with acquired thrombotic thrombocytopenic purpura","volume":"128","author":"Yamaguchi","year":"2001","journal-title":"Thromb. Res."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0090","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0190-9622(99)70124-6","article-title":"Adverse cutaneous reactions to ticlopidine in patients with coronary stents","volume":"41","author":"Yosipovitch","year":"1999","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0095","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1016\/j.jacc.2007.08.016","article-title":"Clopidogrel desensitization after drug-eluting stent placement","volume":"50","author":"Von Thiel","year":"2007","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0100","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1161\/CIRCINTERVENTIONS.108.832964.108.832964","article-title":"Frequency of allergic or hematologic adverse reactions to ticlopidine among patients with allergic or hematologic adverse reactions to clopidogrel","volume":"2","author":"Lokhandwala","year":"2009","journal-title":"Circ. Cardiovasc. Intervent."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0105","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1016\/j.jacc.2011.06.040","article-title":"Characterization of clopidogrel hypersensitivity reactions and managment with oral steroid without clopidogrel disconntinuatiion","volume":"58","author":"Cheema","year":"2011","journal-title":"J. Am. Coll. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0110","first-page":"40","article-title":"Fixed drug eruption from ticlopidine with positive lesional patch test","volume":"44","author":"Martin-Garcia","year":"2001","journal-title":"Contact Dermatitis"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0115","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1345\/aph.1A081","article-title":"Multiple fixed-drug eruption and diarrhea with ticlopidine","volume":"36","author":"Borr\u00e1s-Blasco","year":"2002","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0120","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/j.1468-3083.2009.03115.x","article-title":"Clopidogrel induced fixed drug eruption","volume":"23","author":"Ghosh","year":"2009","journal-title":"J. Eur. Acad. Dermatol. Venereol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0125","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1046\/j.1365-2133.2000.03390.x","article-title":"Acute generalized exanthematous pustulosis following use of ticlopidine","volume":"142","author":"Cannav\u00f2","year":"2000","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0130","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1111\/j.1365-2133.2010.09705.x","article-title":"Clopidogrel-induced acute generalized exanthematous pustulosis with elevated Th17 cytokine levels as determined by a drug lymphocyte stimulation test","volume":"162","author":"Nakamizo","year":"2010","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0135","first-page":"181","article-title":"Clopidogrel associated acute generalized exanthematous pustulosis","volume":"87","author":"Ellebroeck","year":"2011","journal-title":"Cutis"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0140","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/j.1365-2133.2006.07380.x","article-title":"Sub-erythrodermic pustular psoriasis induced by clopidogrel","volume":"155","author":"Meissner","year":"2006","journal-title":"Brit. J. Dermatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0145","doi-asserted-by":"crossref","first-page":"e461","DOI":"10.1111\/ijd.12508","article-title":"Acute generalized exanthematous pustulosis induced by clopidogrel","volume":"53","author":"Ulman","year":"2014","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0150","first-page":"497","article-title":"Lyell syndrome due to ticlopidine","volume":"146","author":"Strippoli","year":"2011","journal-title":"G. Ital. Dermatol. Venereol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0155","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1056\/NEJM199904153401514","article-title":"Toxic erythroderma due to ticlopidine","volume":"340","author":"Hsi","year":"1999","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0160","first-page":"467","article-title":"Toxic epidermal necrolysis after percutaneous coronary intervention: which drug is the culprit?","volume":"124","author":"Hou","year":"2011","journal-title":"Chin. Med. J."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0165","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1046\/j.1365-2133.2003.05209_17.x","article-title":"Clopidogrel bisulphate-induced photosensitive lichenoid eruption: first report","volume":"143","author":"Dogra","year":"2003","journal-title":"Br. J. Dermatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0170","first-page":"e16","article-title":"Clopidogrel and ticlopidene cross-reactivity\u2013induced erythroderma following drug-eluting stenting","volume":"92","author":"Ziakas","year":"2013","journal-title":"Cutis"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0175","first-page":"132","article-title":"Successful desensitization with clopidogrel after a positive skin test","volume":"94","author":"Vigo","year":"2005","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0180","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/j.1398-9995.2005.00749.x","article-title":"Non-immediate reactions to systemic corticosteroids suggest an immunological mechanism","volume":"60","author":"Padial","year":"2005","journal-title":"Allergy"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0185","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0091-6749(96)70279-8","article-title":"Allergic reactions to cyclophosphamide: delayed clinical expression associated with positive immediate skin tests to drug metabolites in five patients","volume":"97","author":"Popescu","year":"1996","journal-title":"J Allergy Clin. Immunol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0190","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1177\/0091270008315310","article-title":"Effects of the proton pump inhibitor lansoprazole on the pharmacokinetics and pharmacodynamics of prasugrel and clopidogrel","volume":"48","author":"Small","year":"2008","journal-title":"J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0195","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1136\/bmj.324.7328.27","article-title":"Ticlopidine associated with acute arthritis","volume":"324","author":"Dakik","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0200","first-page":"48","article-title":"Clopidogrel associated with acute arthritis","volume":"320","author":"Garg","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0205","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1445-5994.2003.00496.x","article-title":"Clopidogrel-associated acute arthritis","volume":"33","author":"Chen","year":"2003","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0210","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1097\/01.RHU.0000062515.74319.4b","article-title":"Acute inflammatory arthritis: an adverse effect of clopidogrel?","volume":"9","author":"Blauwet","year":"2003","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0215","first-page":"670","article-title":"Acute polyarthritis associated with clopidogrel treatment","volume":"7","author":"Boulman","year":"2005","journal-title":"Isr. Med. Assoc J."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0220","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1097\/RHU.0b013e31818272a6","article-title":"Acute arthritis associated with loading dose of clopidogrel","volume":"14","author":"Tayyareci","year":"2008","journal-title":"J. Clin. Rheumatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0225","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s00296-009-1267-y","article-title":"Clopidogrel associated acute arthritis","volume":"32","author":"Kawashiri","year":"2012","journal-title":"Rheumatol. Int."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0230","article-title":"Clopidogrel-induced recurrent polyarthritis","volume":"1","author":"Agrawal","year":"2013","journal-title":"J. Invest. Med. High Impact Case Rep."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0235","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1046\/j.0306-5251.2003.01918.x","article-title":"Seum sickness like reaction associated to clopidogrel","volume":"56","author":"Philips","year":"2003","journal-title":"Brit. J. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0240","doi-asserted-by":"crossref","first-page":"171","DOI":"10.3109\/15569527.2011.627578","article-title":"Leucocytoclastic vasculitis associated to clopidogrel","volume":"31","author":"Erpolat","year":"2012","journal-title":"Cutan. Ocul. Toxicol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0245","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2012-007861","article-title":"Leucocytoclastic vaculitis as late complication of clopidogrel therapy","author":"Shetty","year":"2013","journal-title":"BMJ Case Rep."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0250","doi-asserted-by":"crossref","first-page":"3580","DOI":"10.1172\/JCI38576","article-title":"The ADP receptor P2RY12 regulates osteoclast function and pathologic bone remodeling","volume":"122","author":"Su","year":"2012","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0255","article-title":"Clopidogrel, a P2Y12 receptor antagonist, potentiates the inflammatory response in a rat model of peptidoglycan polysaccharide-induced arthritis","volume":"6","author":"Garcia","year":"2011","journal-title":"PLoS"},{"issue":"e69093","key":"10.1016\/j.ijcard.2016.07.115_bb0260","first-page":"1","article-title":"Erosive arthritis and hepatic granuloma formation induced by peptidoglycan polysaccharid in rats is aggravated by prasugrel treatment","volume":"8","author":"Garcia","year":"2013","journal-title":"PLoS"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0265","first-page":"e137","article-title":"Prasugrel as a safe alternative for clopidogrel-associated arthritis","volume":"23","author":"Kanadiya","year":"2011","journal-title":"J. Invasive Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0270","doi-asserted-by":"crossref","first-page":"855","DOI":"10.3899\/jrheum.081131","article-title":"Ticlopidine as a safe alternative for clopidogrel-associated arthritis","volume":"36","author":"Khan","year":"2009","journal-title":"J. Rheumatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0275","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.1002\/PHAR.1044","article-title":"Prasugrel as a safe alternative for clopidogrel-induced polyarthralgias","volume":"32","author":"Coulter","year":"2012","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0280","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2146\/ajhp130518","article-title":"Resolution of clopidogrel-associated polyarthritis after conversion to prasugrel","volume":"71","author":"Williams","year":"2014","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0285","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/archinte.162.19.2240","article-title":"Ticlopidine-induced lupus: a report of 4 cases","volume":"162","author":"Spiera","year":"2002","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0290","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3109\/s10165-010-0289-3","article-title":"Two cases of late-onset drug-induced lupus erythematosus caused by ticlopidine in elderly men","volume":"20","author":"Yokoyama","year":"2010","journal-title":"Mod. Rheumatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0295","doi-asserted-by":"crossref","first-page":"2685","DOI":"10.1093\/ndt\/gfh432","article-title":"Ticlopidine induces lupus in a haemodialysis patient","volume":"19","author":"Okada","year":"2004","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0300","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1093\/ndt\/gfl028","article-title":"Ticlopidine-induced lupus with renal involvement","volume":"21","author":"Ohtake","year":"2006","journal-title":"Nephrol. Dial. Transplant."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0305","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/j.1365-4632.2006.02783.x","article-title":"Drug-induced subacute cutaneous lupus erythematosus resulting from ticlopidine","volume":"45","author":"Reich","year":"2006","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0310","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.dsi.2014.01.001","article-title":"Ticlopidine-induced subacute cutaneous lupus erythematosus : a case report and literature review","volume":"32","author":"Chen","year":"2014","journal-title":"Dermatol. Sin."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0315","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1111\/j.1365-4632.2005.02366b.x","article-title":"Clopidogrel induced hypersensitivity syndrome associated with febrile pancytopenia","volume":"44","author":"Comert","year":"2005","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0320","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.4065\/80.10.1368","article-title":"Clopidogrel hypersensitivity syndrome with rash, fever and neutropeina","volume":"80","author":"Doogue","year":"2005","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0325","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1001\/archinte.161.1.125","article-title":"Febrile pancytopenia associated with clopidogrel","volume":"161","author":"Andres","year":"2001","journal-title":"Arch. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0330","doi-asserted-by":"crossref","first-page":"305","DOI":"10.7326\/0003-4819-135-4-200108210-00028","article-title":"Severe hypersensitivity associated with clopidogrel","volume":"135","author":"Sarrot-Reynauld","year":"2001","journal-title":"Ann. Intern. Med."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0335","first-page":"262","article-title":"Diffuse alveolar damage associated with ticlopidine use: a case report","volume":"102","author":"Oon","year":"2003","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0340","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1253\/circj.66.773","article-title":"Interstitial pneumoniae induced by ticlopidine","volume":"66","author":"Nakamura","year":"2002","journal-title":"Circ. J."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0345","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1378\/chest.119.6.1963","article-title":"Ticlopidine-induced interstitial pulmonary disease: a case report","volume":"119","author":"Persoz","year":"2001","journal-title":"Chest"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0350","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1023\/A:1026658320577","article-title":"Ticlopidine-induced cholestatic hepatitis: report of three cases and review of literature","volume":"43","author":"Ibqual","year":"1998","journal-title":"Dig. Dis. Sci."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0355","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1592\/phco.29.5.608","article-title":"Clopidogrel-induced hepatocellular injury and cholestatic jaundice in an elderly patient: case report and review of the literature","volume":"29","author":"Goyal","year":"2009","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0360","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1046\/j.1445-5994.2002.00241.x","article-title":"Ticlopidine associated cholestatic hepatitis","volume":"32","author":"Adams","year":"2002","journal-title":"Intern. Med. J."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0365","first-page":"414","article-title":"Clopidogrel induced hepatotoxicity after percutaneous coronary stenting","volume":"11","author":"Chau Tn Yim","year":"2005","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0370","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1097\/00042737-199410000-00018","article-title":"Ticlopidine induced cholestasis: reports of two cases and experimental evidence of the drug adverse effect in the isolated perfused rat liver","volume":"6","author":"Alvaro","year":"1994","journal-title":"Eur. J. Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0375","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.freeradbiomed.2013.06.007","article-title":"Hepatocellular toxicity of clopidogrel: mechanisms and risk factors","volume":"65","author":"Zahno","year":"2013","journal-title":"Free Radic. Biol. Med."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0380","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1345\/aph.1A406","article-title":"Ticlopidine-induced cholestatic hepatitis","volume":"37","author":"Skurnik","year":"2003","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0385","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/j.1572-0241.2002.05642.x","article-title":"Ticlopidine-induced cholestatic hepatitis successfully treated with corticosteroids","volume":"97","author":"Alberti","year":"2002","journal-title":"Am. J. Gastroenterol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0390","first-page":"208","article-title":"Cholestatic hepatitis and anemia induced by ticlopidine","volume":"19","author":"Pascual","year":"1996","journal-title":"Gastroenterol. Hepatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0395","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/(SICI)1096-8652(199811)59:3<260::AID-AJH16>3.0.CO;2-5","article-title":"Early ticlopidine induced hepatitic dysfunction, dermatitis and irreversible aplastic anemia after coronary artery stenting","volume":"59","author":"Ceylan","year":"1998","journal-title":"Am. J. Haematol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0400","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1097\/00004836-200401000-00018","article-title":"Ticlopidine induced acute cholestatic hepatitis complicated with pure red cell aplasia","volume":"38","author":"Yamamoto","year":"2004","journal-title":"J. Clin. Gastroenterol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0405","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1592\/phco.26.7.1023","article-title":"Clopidogrel induced hepatotoxicity and fever","volume":"26","author":"Ng","year":"2006","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0410","first-page":"323","article-title":"Hepatic toxicity and clopidogrel-induced systemic inflammatory response syndrome","volume":"60","author":"Lo'pez-Vicente","year":"2007","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0415","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1177\/106002809502900618","article-title":"Ticopidine-induced granulomatous hepatitis","volume":"29","author":"Ruiz-Valverde","year":"1995","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0420","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/sj.tpj.6500442","article-title":"Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case\u2013control study","volume":"8","author":"Hirata","year":"2008","journal-title":"Pharmacogenomics J."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0425","first-page":"866","article-title":"Ticlopidine-induced cholestatic hepatitis with anti-nuclear antibody in serum","volume":"99","author":"Tsai","year":"2000","journal-title":"J. Formos. Med. Assoc."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0430","first-page":"57","article-title":"Prolonged jaundice following percutaneous coronary intervention and ticlopidine therapy","volume":"8","author":"Tsui","year":"2002","journal-title":"Hong Kong Med. J."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0435","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1345\/aph.18435","article-title":"Successful use of clopidogrel for cerebrovascular accident in a patient with suspected ticlopidine-induced hepatotoxicity","volume":"33","author":"Zeolla","year":"1999","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0440","first-page":"773","article-title":"Managment of a hypersensitivity reaction to thienopyridines: prasugrel induced fever and hepatitis resolved after switching to clopidogrel","volume":"65","author":"Fernandez-Ruiz","year":"2012","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0445","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1016\/j.hlc.2015.04.183","article-title":"An extraordinary case associated with an allergic reaction to clopidogrel: coronary artery spasm or Kounis syndrome?","volume":"24","author":"Liping","year":"2015","journal-title":"Heart Lung Circ."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0450","doi-asserted-by":"crossref","first-page":"e119","DOI":"10.1097\/MJT.0b013e3181cdb98c","article-title":"Recurrent acute stent thrombosis due to allergic reaction secondary to clopidogrel therapy","volume":"18","author":"Karabay","year":"2011","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0455","doi-asserted-by":"crossref","first-page":"618","DOI":"10.4065\/78.5.618","article-title":"Clopidogrel induced systemic inflammatory response syndrome","volume":"78","author":"Wolf","year":"2003","journal-title":"Mayo Clin. Proc."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0460","first-page":"323","article-title":"Hepatic toxicity and clopidogrel induced systemic inflammatory response syndrome","volume":"60","author":"Lopez-Vincente","year":"2007","journal-title":"Rev. Esp. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0465","doi-asserted-by":"crossref","first-page":"e229","DOI":"10.1097\/MJT.0b013e31828fdb1c","article-title":"Fatal sepsi and systemic inflammatory response syndrome after off-label prasugrel: a case report","volume":"21","author":"Serebruany","year":"2014","journal-title":"Am. J. Ther."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0470","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00395-009-0073-8","article-title":"Clopidogrel affects leukocyte dependent platelet aggregation by P2Y12 expressing leukocytes","volume":"105","author":"Diehl","year":"2010","journal-title":"Basic Res. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0475","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1471-2172-5-16","article-title":"P2 receptor mRNA expression profiles in human lymphocytes, monocytes and CD34+ stem and progenitor cells","volume":"5","author":"Wang","year":"2004","journal-title":"BMC Immunol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0480","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1021\/tx980058f","article-title":"Role of drug disposition in drug hypersensitivity: a chemical, molecular and clinical perspective","volume":"11","author":"Park","year":"1998","journal-title":"Chem. Res. Toxicol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0485","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S0090-9556(24)15339-1","article-title":"Metabolism of ticlopidine by activated neutrophils: implications for ticlopidine-induced agranulocytosis","volume":"28","author":"Liu","year":"2000","journal-title":"Drug Metab. Dispos."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0490","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.tox.2013.03.002","article-title":"Toxicity of thienopyridines on human neutrophil granulocytes and lymphocytes","volume":"308","author":"Maseneni","year":"2013","journal-title":"Toxicology"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0495","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2230.2003.01239.x","article-title":"Contact allergy: the role of skin chemistry and metabolism","volume":"28","author":"Smith Pease","year":"2003","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0500","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1345\/aph.1G587","article-title":"Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents","volume":"40","author":"Makkar","year":"2006","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0510","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1016\/j.ijcard.2011.09.051","article-title":"Allergic reaction to prasugrel and cross-reactivity with clopidogrel","volume":"157","author":"Raccah","year":"2012","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0515","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1097\/00130832-200308000-00005","article-title":"Cross-reactivity with drugs at the T cell level","volume":"3","author":"Depta","year":"2003","journal-title":"Curr. Opin. Allergy Clin. Immunol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0520","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1586\/ecp.10.30","article-title":"Clopidogrel hypersensitivity: clinical challenges and options for management","volume":"3","author":"Campbell","year":"2010","journal-title":"Expert. Rev. Clin. Pharmacol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0525","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1007\/s40265-015-0414-x","article-title":"Management strategies for clopidogrel hypersensitivity","volume":"75","author":"Beavers","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0530","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjcard.2010.11.002","article-title":"Management of clopidogrel hypersensitivity without drug interruption","volume":"107","author":"Campbell","year":"2011","journal-title":"Am. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0535","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1592\/phco.28.2.259","article-title":"Clopidogrel desensitization: case report and review of published protocol","volume":"28","author":"Owen","year":"2008","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0540","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.anai.2011.11.005","article-title":"Desensitization to prasugrel: cardiology's increased need for allergy consultation","volume":"108","author":"Mutnick","year":"2012","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0545","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/all.12161","article-title":"Desensitization in delayed drug hypersensitivity reactions -- an EAACI position paper of the Drug Allergy Interest Group","volume":"68","author":"Scherer","year":"2013","journal-title":"Allergy"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0550","doi-asserted-by":"crossref","DOI":"10.1136\/hrt.2003.027367","article-title":"Clopidogrel induced urticarial rash in a patient with left main stem percutaneous coronary intervention: management issues","volume":"90","author":"Khambekar","year":"2004","journal-title":"Heart"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0555","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/09537104.2010.514627","article-title":"Prasugrel as alternative treatment strategy in a case with a hypersensitivity reaction to clopidogrel","volume":"22","author":"van Werkum","year":"2011","journal-title":"Platelets"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0560","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/j.anai.2011.08.003","article-title":"Successful use of prasugrel, an alternative antiplatelet agent, in a patient with clopidogrel allergy","volume":"107","author":"Chopra","year":"2011","journal-title":"Ann. Allergy Asthma Immunol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0565","doi-asserted-by":"crossref","DOI":"10.1345\/aph.1Q287","article-title":"Use of prasugrel in a patient with clopidogrel hypersensitivity","volume":"45","author":"Peppard","year":"2011","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0570","doi-asserted-by":"crossref","first-page":"511","DOI":"10.2146\/ajhp120529","article-title":"Prasugrel use in a patient allergic to clopidogrel: effect of a drug shortage on selection of dual antiplatelet therapy","volume":"70","author":"Felix-Getzik","year":"2013","journal-title":"Am. J. Health Syst. Pharm."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0575","first-page":"e211","article-title":"Use of ticlopidine and cilostazol after intracoronary drug-eluting stent placement in a patient with previous clopidogrel-induced thrombotic thrombocytopenic purpura: a case report","volume":"18","author":"Patel","year":"2006","journal-title":"J. Invasive Cardiol."},{"issue":"869","key":"10.1016\/j.ijcard.2016.07.115_bb0580","first-page":"e9","article-title":"Prasugrel as an alternative for clopidogrel-associated neutropenia","volume":"27","author":"Khangura","year":"2011","journal-title":"Can. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0585","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1345\/aph.1R062","article-title":"Prasugrel-induced rash","volume":"46","author":"Deshmukh","year":"2012","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0590","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4070\/kcj.2014.44.5.355","article-title":"Prasugrel-induced hypersensitivity skin reaction","volume":"44","author":"Kim","year":"2014","journal-title":"Korean Circ. J."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0595","doi-asserted-by":"crossref","first-page":"4381","DOI":"10.1016\/j.ijcard.2013.05.051","article-title":"A strategy of 'treating through' a prasugrel-induced rash","volume":"168","author":"Yang","year":"2013","journal-title":"Int. J. Cardiol."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0600","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1002\/phar.1477","article-title":"Ticagrelor: pharmacokinetics, pharmaco-dynamics, clinical efficacy, and safety","volume":"34","author":"Dobesh","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0605","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1002\/phar.1446","article-title":"Acute coronary syndrome antiplatelet alternatives in clopidogrel allergy","volume":"34","author":"Manchette","year":"2014","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.ijcard.2016.07.115_bb0610","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1177\/1060028014539143","article-title":"Ticagrelor use in a patient with a documented clopidogrel hypersensitivity","volume":"48","author":"Harris","year":"2014","journal-title":"Ann. Pharmacother."},{"key":"10.1016\/j.ijcard.2016.07.115_bb0615","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3109\/09537104.2013.867427","article-title":"Ticagrelor as an alternative in clopidogrel-associated neutropenia","volume":"26","author":"Shah","year":"2015","journal-title":"Platelets"}],"container-title":["International Journal of Cardiology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731631467X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S016752731631467X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T01:42:57Z","timestamp":1749001377000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S016752731631467X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,11]]},"references-count":122,"alternative-id":["S016752731631467X"],"URL":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.115","relation":{},"ISSN":["0167-5273"],"issn-type":[{"value":"0167-5273","type":"print"}],"subject":[],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A joint allergist\/cardiologist classification for thienopyridines hypersensitivity reactions based on their symptomatic patterns and its impact on the management strategies","name":"articletitle","label":"Article Title"},{"value":"International Journal of Cardiology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ijcard.2016.07.115","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ireland Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}